Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease

Journal of Neural Transmission

Volumn 105, Issue 6-7, 1998, Pages 709-717

  Sabbagh, M N ^a,b,e   Reid, R T ^c   Corey Bloom, J ^a,b   Rao, T S ^c   Hansen, L A ^a   Alford, M ^a   Masliah, E ^a   Adem, A ^d   Lloyd, G K ^c   Thal, L J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Binding; Nicotinic receptor

Indexed keywords

CHOLINE ACETYLTRANSFERASE; EPIBATIDINE; NICOTINIC RECEPTOR; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; SYNAPSE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BICYCLO COMPOUNDS, HETEROCYCLIC; BIOLOGICAL MARKERS; BRAIN; CHOLINE O-ACETYLTRANSFERASE; COGNITION DISORDERS; HUMANS; NICOTINIC AGONISTS; PYRIDINES; RECEPTORS, NICOTINIC; REFERENCE VALUES; SYNAPSES; SYNAPTOPHYSIN;

EID: 15444361108     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050090     Document Type: Article

References (47)

1. Alford MF, Masliah E, Hansen LA, Terry RD (1994) A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J Histochem Cytochem 42: 283-287
2. Aubert I, Araujo DM, Cecyre D, Robitaelle Y, Gauthier S, Quirion R (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem 58: 529-541
3. Bierer LM, Haroutanian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schneidler J, Kanof P, Davis KL (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64: 749-760
4. Blessed G, Tomlinson BE, Roth M (1968) The associations between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797-811
5. Braak H, Braak E (1994) Pathology of Alzheimer's disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585-613
6. Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii: 1403
7. de la Torre JC, Goldsmith HS (1992) Supraspinal fiber outgrowth and apparent synaptic remodelling across transected-reconstructed feline spinal cord. Acta Neurochir 114: 118-127
8. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457-464
9. Flynn DD, Mash DC (1986) Characterization of L-[3H]Nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J Neurochem 47: 1948-1954
10. Fonnum F (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase and acetylcholinesterase activities. Biochem J 115: 465-472
11. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS (1985) Neurochemical studies of early-onset Alzheimer's disease: possible influence on treatment. N Engl J Med 313:7-11
12. Giacobini E (1992) Nicotine acetylcholine receptors in human cortex: aging and Alzheimer's disease. In: Lippiello, PNM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine: current research issues. Raven Press, New York, pp 183-194
13. Giacobini E, DeSarno P, Mcllhany M, Clark B (1988) The cholinergic receptors system in the frontal lobe of Alzheimer patients. In: Clementi F, Botti C, Sher E (eds) Nicotinic acetylcholine receptors in the nervous system. Springer, New York, pp 367-378
14. Hansen LA, DeTeresa R, Tobias H, Alford M, Terry RD (1988a) Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol 131: 507-518
15. Hansen LA, DeTeresa R, Davies P, Terry RD (1988b) Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 38: 48-54
16. Houghtling RA, Davila-Garcia MI, Kellar KJ (1995) Characterization of (+/-)(-) [3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48(2): 280-287
17. James JR, Nordberg A (1995) Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet 25: 149-159
18. Kellar KJ, Wonnacott S (1990) Nicotinic cholinergic receptors in Alzheimer's disease. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology. Oxford University Press, London, pp 341-373
19. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL (1987) Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res 436(1): 62-68
20. Khatchaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
21. Lavine N, Reuben M, Clarke PBS (1997) A population of nicotinic receptors is associated with thalamocortical afferents in the adult rat: Iaminal and areal analysis. J Comp Neurol 380: 175-190
22. McGehee DS, Role LW (1996) Presynaptic ionotropic receptors. Curr Opin Neurobiol 6: 342-349
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944
24. 3H]-acetylcholine release in the rat cerebral cortex. J Neurochem 49: 1758-1762
25. Mirra SS, Heyman A, McKee D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, VanBelle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD), part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
26. Miyai I, Ueno S, Yorifuji S, Fujimura H, Tarui S (1990) Alterations in neocortical expression of nicotinic acetycholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis. J Neural Transm 82: 79-91
27. Nordberg A (1992a) Neuroreceptor changes in Alzheimer's disease. Cerebrovasc Brain Metab Rev 4: 303-328
28. Nordberg A (1994) Human nicotinic receptors-their role in aging and dementia. Neurochem Int 25: 93-97
29. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 2(1): 115-119
30. Nordberg A, Alafuzoff I, Winblad B (1992b) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res 31: 103-111
31. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457-1459
32. Perry EK, Smith CJ, Court JA, Perry RH (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson, and Lewy body types. J Neural Transm 2: 149-158
33. Perry EK, Morris CM, Court JA, Chevez A, Faubairn AF, McKeith IG, Irving D, Brown A, Perry RH (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia, and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64: 385-395
34. Prusky GT, Shaw C, Cyander MS (1987) Nicotine receptors are located on lateral geniculate nucleus terminals in cat visual cortex. Brain Res 412: 131-138
35. Rinne J, Myllkyla T, Lonnberg P, Marjamaki P (1991) A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res 547: 167-170
36. Role LW, Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16: 1077-1085
37. Romijn HJ, van Marie J, Janszen AW (1993) Permanent increase of the GAD67/ synaptophysin ratio in rat cerebral cortex nerve endings as a result of hypoxic ischemic encephalopathy sustained in early postnatal life: a confocal laser scanning microscopic study. Brain Res 630: 315-329
38. Schroder H, Giacobini E, Struble RG, Zilles K, Maelicke A (1991a) Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol Aging 12: 259-262
39. Schroder H, Giacobini E, Struble RG, Zilles K, Maelicke A, Luiten PG, Strosberg AD (1991b) Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease. Ann NY Acad Sci 640: 189-192
40. Schwartz RD, Lehmann J, Kellar K (1987) Presynaptic nicotinic cholinergic receptors labeled by [3H-acetylcholine on catecholamine and serotonin axons in the brain. J Neurochem 42: 1495-1498
41. Sugaya K, Giacobini E, Chiappinelli VA (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J Neurosci Res 27: 349-359
42. Terry R, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10: 184-192
43. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580
44. Torack RM, Miller JW (1995) Denervation induced abnormal phosphorylation in hippocampal neurons. Brain Res 669: 135-139
45. Warpman U, Nordberg A (1995) Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. Neuroreport 6: 2419-2423
46. Wilcock GK, Esiri MM, Bowen DM, Smith CC (1982) Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57: 407-417
47. Wonnacott S, Soilakov L, Wilkie G, Redfervn P, Marshall D (1996) Presynaptic nicotinic acetylcholine receptors in the brain. Drug Dev Res 38: 149-159